What is the clinical evidence from this study?

Study design: Observational. Population: Lp(a) concentrations and cardiovascular events (n=512). Intervention: Lp(a) Testing vs. No testing. Primary outcome: Routine Lp(a) Testing rates.

What does this research mean for the field?

Lp(a) testing rates among physicians in Latin America are low, with only 36.6% routinely requesting it. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

What question did this study set out to answer?

The aim is to assess the awareness and clinical application of Lp(a) testing among medical society physicians in Latin America.

January 9, 2026BMC Cardiovascular DisordersOpen Access

Lp(a) Testing in Latin America: Low Awareness and Clinicalpractice Among Medical Society Physicians Highlight a Missed Opportunity in Cardiovascular Prevention

View Full Paper

Ask AI

Bookmark

Key result

Lp(a) testing rates among physicians in Latin America are low, with only 36.6% routinely requesting it.

Authors

ICIvette Cruz‐BautistaInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán YFYuscely Flores-JuradoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ABAntonio Barajas-Martínez

Discussion

Member takes

Implication

Awareness and clinical use of Lp(a) testing among physicians indicates missed opportunities for cardiovascular prevention.

Key Points

The aim is to assess the awareness and clinical application of Lp(a) testing among medical society physicians in Latin America.
Surveyed physicians on their awareness of Lp(a) testing.
Analyzed clinical practices related to Lp(a) testing.
Evaluated the barriers to adopting Lp(a) testing in routine assessments.
Most physicians lack awareness about Lp(a) testing.
Clinical use is largely limited to high-risk patients.
Recommendations for improving accessibility and guidelines could bolster testing adoption.

Study Design

Type

Observational (n=512)

Multicenter

Yes

PICO

Population

Lp(a) concentrations and cardiovascular events (n=512)

Intervention / Comparator

Lp(a) Testing vs No testing

Primary Outcome

Routine Lp(a) Testing rates

Limitations

Low awareness among physicians
Limited access to Lp(a) testing
High costs associated with testing

Cite This Study

Cruz‐Bautista et al. (2025) conducted an observational in Lp(a) concentrations and cardiovascular events (n=512). Lp(a) Testing vs. No testing was evaluated on Routine Lp(a) Testing rates. Lp(a) testing rates among physicians in Latin America are low, with only 36.6% routinely requesting it.

synapsesocial.com/papers/69612fe730ef6c21f6853fca https://doi.org/10.1186/s12872-025-05461-6

View Full Paper

Ask AI

Bookmark

Lp(a) Testing in Latin America: Low Awareness and Clinicalpractice Among Medical Society Physicians Highlight a Missed Opportunity in Cardiovascular Prevention

Discussion

Member takes

Implication

Key Points

Study Design

PICO

Limitations

Cite This Study

Lp(a) Testing in Latin America: Low Awareness and Clinicalpractice Among Medical Society Physicians Highlight a Missed Opportunity in Cardiovascular Prevention

Discussion

Member takes

Implication

Key Points

Study Design

PICO

Limitations

Cite This Study

Also Consider

Also Consider